CIITA and MHC class II deficiency: In accordance with the relevance of CD4 + T cells and CIITA-driven HLA-II presentation, BLS patients frequently suffer from severe, persistent HCMV infections (Elhasid and Etzioni, 1996; Klein et al., 1993).